Archive

A pill for peanut allergies? | TribLIVE.com
Health

A pill for peanut allergies?

phpGTWnutlunch2121312
Pittsburgh Tribune-Review
School districts and food-service managers handle peanut allergies in different ways. ARNAUD WEISSER | FOR THE TRIBUNE-REVIEW

Pills containing peanut protein can act like a vaccine for the immune system and could reduce the severity of an allergic reaction to peanuts, according to a new research studty.

The goal of the treatment is not to try to cure the allergy, but to train the immune system of an allergic person not to react as severely if exposed to a small amount of peanut. It works by slowly, over time, desensitizing the patient with increasing doses of the allergy-inducing culprit, according to a study published in the Journal of Allergy and Clinical Immunology: In Practice.

The study is seeking to measure the possible effectiveness of the method was conducted on 29 people between the ages of 4 and 26 in 10 U.S. cities, plus another 26 in a control group.

Each of the group of 29 participants in the study was given an experimental drug containing peanut flour packed in a pill. Those in the control group were given pills containing only oat flour.

During a six-month period, participants receiving the peanut-flour pills were given gradually stronger doses of the powder.

People in both groups were then given a “food challenge,” with exposure to about one and a half peanuts. Among those in the group who had been taking the peanut pills, 79 percent exhibited no reactions to the allergen, ABC News said.

“It’s great to have patients go from managing to tolerate at most the amount of peanut protein in a 10th of a peanut without reacting, to successfully eating the equivalent of between two to four peanuts with nothing more than mild, transient symptoms, if any at all,” said study co-author Dr. A. Wesley Burks, a professor of pediatrics at the University of North Carolina.

More and larger studies will be needed before the treatment can be proven to work and submitted for FDA approval.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.